non-
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (≥18 year-old) Newly diagnosed, treatment-naïve, pathologically confirmed advanced stage NSCLC Sign informed consent
Exclusion criteria
Exclusion criteria: Prior systemic therapies, including cytotoxic chemotherapy, small molecule targeted therapy, immunotherapy History of another malignancy within 5 years before enrollment Receipt of corticosteroids or any immunosuppressive agents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protein expression on PBMC At enrollment Flow cytometric analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Contacts
Chulalongkorn University